Sympa Health Takes 2nd Place at the China (Shenzhen) Innovation and Entrepreneurship International Competition – Spain Division

Advancing to the Industry Finals on a Global Stage

We are proud to share that Sympa Health has been awarded 2nd Prize at the 9th China (Shenzhen) Innovation and Entrepreneurship International Competition, Spain Division - and has qualified for the upcoming Industry Finals.

About the Competition

The China (Shenzhen) Innovation and Entrepreneurship International Competition is one of the most prestigious global startup competitions, connecting innovative teams from around the world with one of the most dynamic innovation ecosystems on the planet. This year's Spain Division attracted 224 teams in the preliminary round, with only 21 advancing to the divisional finals held in Barcelona. From those, 14 teams - including Sympa Health - have now earned their place in the Industry Finals.

Shenzhen, the competition's home base, is globally recognised as a hub for technology, deep-tech manufacturing, and entrepreneurial ambition. Being part of this competition places Sympa Health in the company of some of the most forward-thinking startups emerging from Europe and beyond.

What This Means for Sympa Health

Competing against teams spanning advanced materials, energy technology, and life sciences - and earning 2nd place - is a strong signal that the problem Sympa Health is solving resonates far beyond the FemTech sector alone. Women's health is a global challenge, and the recognition we received in Barcelona reflects a growing understanding that innovative, technology-driven solutions in this space deserve serious attention on the world stage.

The jury's feedback was invaluable, and we leave the divisional finals with both recognition and sharper insight into how we continue building.

Looking Ahead to the Industry Finals

Qualifying for the Industry Finals means Sympa Health will now compete at the next level - alongside the strongest teams from across all divisions. We are committed to representing women's health with the same focus and determination that brought us here.

This milestone reinforces our belief that building a science-backed, accessible platform for women navigating endometriosis is not only the right mission - it is one the world is ready for.